Non-Invasive Diaphragm Stimulation: Market Feasibility Study in Europe

dc.contributor.authorAugustin, Joshua
dc.contributor.authorStark, Philippe
dc.contributor.partnerSTIMIT AG, 2503 Biel-Bienne
dc.date.accessioned2024-12-03T19:39:05Z
dc.date.available2024-12-03T19:39:05Z
dc.date.issued2024
dc.description.abstractAfter achieving promising clinical data in clinical trials and progressing towards regulatory approval in the US and Canada, which is the current focus, STIMIT AG is exploring the global potential including Europe. By late 2023, the company completed North American market research and is now seeking to identify the most promising markets for its non-invasive diaphragm stimulation device. This thesis investigates which European country may offer the best market potential for STIMIT’s product.
dc.identifier.urihttps://irf.fhnw.ch/handle/11654/49256
dc.language.isoen
dc.publisherHochschule für Wirtschaft FHNW
dc.spatialOlten
dc.subject.ddc330 - Wirtschaft
dc.titleNon-Invasive Diaphragm Stimulation: Market Feasibility Study in Europe
dc.type11 - Studentische Arbeit
dspace.entity.typePublication
fhnw.InventedHereYes
fhnw.StudentsWorkTypeBachelor
fhnw.affiliation.hochschuleHochschule für Wirtschaft FHNWde_CH
fhnw.affiliation.institutBachelor of Science
Dateien